C
Carolyn Siebert
Researcher at National Institutes of Health
Publications - 11
Citations - 21751
Carolyn Siebert is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Diabetes mellitus & Insulin. The author has an hindex of 8, co-authored 11 publications receiving 20775 citations.
Papers
More filters
Journal ArticleDOI
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
Diabetes Control,David M. Nathan,Saul M. Genuth,John M. Lachin,Patricia A. Cleary,O Crofford,Matthew M. Davis,Larry Rand,Carolyn Siebert +8 more
TL;DR: Intensive therapy effectively delays the onset and slows the progression of diabetic retinopathy, nephropathy, and neuropathy in patients with IDDM.
Journal ArticleDOI
Glomerular filtration rate measurements in clinical trials
Andrew S. Levey,Andrew S. Levey,Tom Greene,Mark D. Schluchter,Patricia A. Cleary,Paul E. Teschan,Rodney A. Lorenz,Mark E. Molitch,William E. Mitch,Carolyn Siebert,Phillip M. Hall,Michael W. Steffes +11 more
TL;DR: The utility and precision of GFR measurements in multicenter trials, analyzed in 2,250 patients enrolled in 44 clinical centers participating in either the Modification of Diet in Renal Disease (MDRD) Study or the Diabetes Control and Complications Trial (DCCT), was excellent.
Journal ArticleDOI
Extreme insulin resistance in ataxia telangiectasia: defect in affinity of insulin receptors.
Robert S. Bar,W R Levis,Matthew M. Rechler,Len C. Harrison,Carolyn Siebert,Judith M. Podskalny,Jesse Roth,Michele Muggeo +7 more
TL;DR: The insulin resistance in the two siblings with ataxia telangiectasia was associated with defects in the affinity of the receptors for insulin, probably caused by circulating inhibitors of insulin binding.
Journal ArticleDOI
Insulin receptors in patients with insulinomas: changes in receptor affinity and concentration.
TL;DR: With insulinomas, correlations with the clinical state appear to be clearer when receptor concentration and especially receptor affinity are considered in addition to circulating insulin and proinsulin levels.
Journal ArticleDOI
The DCCT and medical care for diabetes in the U.S.
TL;DR: Intensive treatment of insulin-dependent diabetes mellitus can substantially reduce the incidence and progression of retinopathy, nephropathy, and neuropathy.